Guardant Health (GH) insider files to sell 1,803,685 shares valued at $134M

Rhea-AI Filing Summary

Meghan V. Joyce filed a notice relating to potential sales of Guardant Health, Inc. common stock. The filing covers up to 1,803,685 shares to be sold through Charles Schwab & Co., Inc., with an approximate aggregate market value of $134,196,170 and a proposed sale date of 08/05/2026 on NASDAQ.

The notice also lists sales over the prior three months: 10,000 shares for $1,269,809.00 on 06/03/2026, 6,203 shares for $812,604.00 on 06/22/2026, 2,000 shares for $280,045.00 on 06/24/2026, 2,000 shares for $300,082.00 on 06/26/2026, and 4,000 shares for $660,000.00 on 07/01/2026. The securities are described as arising from a restricted stock lapse in connection with equity compensation.

Key Figures

Planned shares to be sold: 1,803,685 shares Approximate aggregate market value: $134,196,170 Proposed sale date: 08/05/2026 +5 more

8 metrics

Planned shares to be sold 1,803,685 shares Common stock covered in the notice through Charles Schwab & Co., Inc.

Approximate aggregate market value $134,196,170 Value associated with the 1,803,685 Guardant Health common shares

Proposed sale date 08/05/2026 Date associated with the potential sale of covered common shares on NASDAQ

Sale on 06/03/2026 10,000 shares for $1,269,809.00 Guardant Health common stock sold by Meghan V. Joyce

Sale on 06/22/2026 6,203 shares for $812,604.00 Guardant Health common stock sold by Meghan V. Joyce

Sale on 06/24/2026 2,000 shares for $280,045.00 Guardant Health common stock sold by Meghan V. Joyce

Sale on 06/26/2026 2,000 shares for $300,082.00 Guardant Health common stock sold by Meghan V. Joyce

Sale on 07/01/2026 4,000 shares for $660,000.00 Guardant Health common stock sold by Meghan V. Joyce

Key Terms

Form 144, Restricted Stock Lapse, Equity Compensation, Approximate market value

4 terms

Form 144 regulatory

"144: Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Lapse financial

"01/04/2023 | Restricted Stock Lapse - See Remarks"

Equity Compensation financial

"01/04/2023 | Equity Compensation"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

Approximate market value financial

"1803685.00 | 134196170 | 08/05/2026 | NASDAQ"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/05/2026 - 04:22 PM Accepted by SEC EDGAR 08/05/2026 - 04:21 PM Learn about SEC filing dates

FAQ

What does the Form 144 filing by Meghan V. Joyce for GH disclose?

The filing discloses a plan for potential sale of up to 1,803,685 Guardant Health common shares through Charles Schwab, with an approximate $134,196,170 aggregate market value and a proposed sale date of 08/05/2026 on NASDAQ.

How many Guardant Health (GH) shares are covered by the planned sale?

The notice covers up to 1,803,685 shares of Guardant Health common stock. These shares are to be sold through Charles Schwab & Co., Inc., with an approximate total market value of $134,196,170 as referenced in the filing.

What recent Guardant Health (GH) share sales are listed in the Form 144?

The filing lists prior three-month sales: 10,000 shares for $1,269,809.00 on 06/03/2026, 6,203 shares for $812,604.00 on 06/22/2026, 2,000 for $280,045.00 on 06/24/2026, 2,000 for $300,082.00 on 06/26/2026, and 4,000 for $660,000.00 on 07/01/2026.

Which broker is involved in the planned Guardant Health (GH) stock sale?

The planned sale of Guardant Health common stock is to be executed through Charles Schwab & Co., Inc. The filing lists the broker’s address at 3000 Schwab Way, Westlake, TX 76262 and indicates trading on NASDAQ.

What type of Guardant Health (GH) securities are referenced in the Form 144?

The filing references common stock of Guardant Health, Inc. It notes that the securities to be sold relate to a Restricted Stock Lapse in connection with equity compensation, with details provided under the remarks section.

On what date is the proposed Guardant Health (GH) stock sale expected?

The proposed sale date for the covered Guardant Health shares is 08/05/2026. This date appears alongside the indicated 1,803,685 shares, an approximate market value of $134,196,170, and the NASDAQ listing reference.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	11183	1803685.00	134196170	08/05/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/04/2023	Restricted Stock Lapse - See Remarks	GUARDANT HEALTH, INC.			11183	01/04/2023	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Meghan V. Joyce 3100 HANOVER STREET PALO ALTO CA 94304	Guardant Health, Inc.	06/03/2026	10000	1269809.00
Meghan V. Joyce 3100 HANOVER STREET PALO ALTO CA 94304	Guardant Health, Inc.	06/22/2026	6203	812604.00
Meghan V. Joyce 3100 HANOVER STREET PALO ALTO CA 94304	Guardant Health, Inc.	06/24/2026	2000	280045.00
Meghan V. Joyce 3100 HANOVER STREET PALO ALTO CA 94304	Guardant Health, Inc.	06/26/2026	2000	300082.00
Meghan V. Joyce 3100 HANOVER STREET PALO ALTO CA 94304	Guardant Health, Inc.	07/01/2026	4000	660000.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)